News
Smooth, SIMPLE, secure: Treating fistulas the easy way.
Improve your patients' lives - one seton at a time.
Master the SuperSeton at ECC St Gallen
Meet SuperSeton at booth #1 at ESCP in Dublin and claim your free samples
Bright times ahead for SuperSeton
SuperSeton is looking forward to meet you at ECC St Gallen
SuperSeton at events in Australia and Austria
Smooth, Simple, Secure: SuperSeton tensile test
SuperSeton goes global with Bridgehead Global Programme
SuperSeton selected for the HUB program, preparing US entry
We wish you a smooth 2021!
SuperSeton Publication: Scientific Report by Nature Publishing Group
Challenging times - competitive prices
SuperSeton slides smoothly into the new year at ACM Valbella 2020!
SuperSeton continues touring Europe - on to ECC in St. Gallen and EIT Health in Paris
SuperSeton Expands Its European Network - Meet Our New Partners
SuperSeton receives innovation loan from Rabobank
ESCP's visitors embrace the SuperSeton!
Meet us at the ESCP in Vienna and try out the SuperSeton
SuperSeton expanding its European activities
SuperSeton European tour – coming to a congress near you!
SuperSeton production commenced – first shipment in May
Positive reception for SuperSeton at IBD-patient day 2019
Launch of SuperSeton product during DDD Congress in the Netherlands
SuperSeton European Market launch at Alpine Colorectal meeting
SuperSeton CE certified
Super Seton Secures Series-A
SuperSeton secures Rabobank financing
Super Seton Secures Series-A
March 7th, 2018Super Seton announces the closing of a series A share issue. The investors are two experienced Healthtech entrepreneurs, Bart Bergstein & Michiel Manuel, who will join the advisory board of the company. SuperSeton is an innovative knotless seton for use in perianal fistula and has been developed by the Amsterdam UMC (Amsterdam University Medical Centre), MediShield and NLC | the Healthtech Venture Builder. The product is expected to be launched in 2018, following CE marking. For more information contact Ernst Elhorst, CEO.
